Is Global Medical REIT, Inc. overvalued or undervalued?

As of 3 August 2021, the valuation grade for Global Medical REIT, Inc. moved from risky to very attractive, indicating a significant improvement in its investment appeal. The company is currently considered undervalued. Key ratios include a P/E ratio of 48, an EV to EBITDA of 4.35, and a Price to Book Value of 0.89, which suggest that while the earnings multiple appears high, the overall valuation metrics are favorable compared to its peers.
In comparison to its peers, Global Medical REIT, Inc. has a P/E ratio of 46.89, while Dynex Capital, Inc. stands at 18.29, highlighting a substantial difference in valuation. Additionally, the EV to EBITDA ratio for Global Medical is 4.25, compared to 2.49 for Dynex Capital, further emphasizing the relative attractiveness of Global Medical despite its higher earnings multiple. Recent stock performance shows that Global Medical has underperformed against the S&P 500, with a year-to-date return of -18.78% compared to the S&P 500's 2.44%, reinforcing the notion that the stock may be undervalued in the current market context.